Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04638894
Other study ID # S63875
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date June 1, 2024

Study information

Verified date January 2024
Source Universitaire Ziekenhuizen KU Leuven
Contact Anna Tarasiuk
Phone 003216 338818
Email orthopedie.research@uzleuven.be
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The study will examine if variability in created value (outcome/costs) over the care cycle for ASD patients can be explained by patient and treatment characteristics.


Description:

Due to budget restrictions in health care, cost is a major challenge, particularly in chronic disorders affecting the ageing population for which advanced but often expensive medical technologies offer benefit. Stakeholders strive to define, assess and improve the so-called "value in healthcare" to achieve the best outcome at the lowest cost of care. First and foremost, the investigator will try to examine if we can explain variability in the created value over the care cycle by patient and treatment characteristics. This knowledge can be used to optimize the value for the patients. Also, the investigator will try to compare the psychometric properties between the different versions of value equations, resulting from the use of different outcome tools to measure value. Adult Spinal Deformity patients can take part in the study. This will be decided by clinical examination and radiographic evaluation and is based on at least one of the following criteria: 1) Coronal spinal curvature ≥20°, 2)Sagittal vertical axis (SVA) >5 cm, 3) Pelvic tilt >25°, 4) Thoracic kyphosis >60°. The patients have to be older than or equal to 18 years old at the time of surgery. In line with the standard of care, the patients will be seen after 3 months, 6 months, 1 year and 2 years postoperatively. Pre- and post-operatively, questionnaires will be completed by the patients. The patient questionnaires EuroQol 5D (EQ-5D-3L and EQ-5D-5L) , Scoliosis Research Society 22 score (SRS-22), Oswestry disability Index, Core Outcome Measures Index score (COMI) and Work status will be completed by the patients during the baseline visit and on each follow-up moment at 3 months, 6 months, 1 year and 2 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date June 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult Spinal Deformity patients - Index Surgery from 15/03/2020 and 15/03/2022 - Age of 18 years old or older at the moment of the index surgery - Patients treated in University Hospitals Leuven - Patient has full understanding and is willing to participate (Informed consent) Exclusion Criteria: - • Patients younger than 18 years old at the moment of index surgery - Patients with an index surgery before 15/03/2020 - Patients treated in other centers outside of University Hospitals Leuven

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Surgical treatment of patients with adult spinal deformity
Including all surgical interventions for patients with adult spinal deformity.

Locations

Country Name City State
Belgium UZ Leuven Leuven Vlaams-Brabant

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Generic Value Generic outcome, measured via the EuroQol 5D (EQ-5D), divided by costs 2 years
Primary Disease specific value: Scoliosis Research Society Outcomes Questionnaire (SRS-22) Disease-specific value, measured via the Scoliosis Research Society Outcomes Questionnaire (SRS-22), divided by costs 2 years
Primary Disease specific value: Oswestry Low Back Pain Disability Questionnaire (ODI) Disease-specific value, measured via the Oswestry Low Back Pain Disability Questionnaire (ODI), divided by costs 2 years
Primary Disease specific value: Core Outcome Measures Index (COMI) Disease-specific value, measured via the Core Outcome Measures Index (COMI), divided by costs 2 years
Secondary Workstatus Workstatus, following the International Consortium for Health Outcomes Measurement (ICHOM) standard low back pain 2 years
Secondary Return to work Return to work, following the International Consortium for Health Outcomes Measurement (ICHOM) standard low back pain 2 years
See also
  Status Clinical Trial Phase
Completed NCT01080547 - Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer Phase 3
Recruiting NCT05360069 - Linear Stapler Versus Circular Stapler in Esophagojejunostomy N/A
Completed NCT02233400 - A Trial of the Cost Effectiveness of IV Acetaminophen in Bariatric Surgery Phase 4